Other
The First Affiliated Hospital of Yunnan University of Traditional Chinese Medicine
Total Trials
3
Recruiting
0
Active
0
Completed
0
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
Failure Rate
0.0%
0 terminated/withdrawn out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed trials have results
Key Signals
Enrollment Performance
Analytics
Early Phase 1
2(66.7%)
Phase 2
1(33.3%)
3Total
Early Phase 1(2)
Phase 2(1)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (3)
Showing 3 of 3 trials
NCT06548139Phase 2Not Yet Recruiting
Rabies mAb CBB 1 Combination Vaccine in Healthy People With Antibody Neutralization Activity and Safety Phase Clinical Trials
Role: collaborator
NCT06360250Early Phase 1Not Yet Recruiting
Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of the Fully Human Anti-tetanus Toxin Monoclonal Antibody A82 / B86 Injection Combination Formulation
Role: collaborator
NCT05832073Early Phase 1Unknown
Safety, Pharmacokinetics, and Pharmacodynamic Testing of Rabies mAb CBB 1
Role: collaborator
All 3 trials loaded